Also to know is, what is a Phase 3 clinical trial?
Phase III of a clinical trial usually involves up to 3,000 participants who have the condition that the new medication is meant to treat. Trials in this phase can last for several years. The purpose of phase III is to evaluate how the new medication works in comparison to existing medications for the same condition.
One may also ask, how long do clinical trial phases take?
Together, clinical trial phases take six to seven years on average. Each individual phase takes a different amount of time, with Phase 3 trials lasting the longest. Before a potential treatment reaches the clinical trial stage, first scientists research ideas in what is called the discovery phase.
How many patients are in Phase 3 trials?
Phase III of a clinical trial usually involves up to 3,000 participants who have the condition that the new medication is meant to treat.
How many clinical trials are required for drug approval?
The FDA typically requires Phase I, II, and III trials to be conducted to determine if the drug can be approved for use. A Phase I trial tests an experimental treatment on a small group of often healthy people (20 to 80) to judge its safety and side effects and to find the correct drug dosage.